PMV Pharmaceuticals PMVP
NASDAQ PMVP
$1.80 +0.05 (+2.86%)
As of: Oct 2, 2026 · 3:26 PM EDT

PMV Pharmaceuticals (PMVP) Depreciation & Amortization (CF) (2019 - 2026)

Updated

PMV Pharmaceuticals (PMVP) posted Depreciation & Amortization (CF) of $24,000 for Q2 2026, down 25.0% from $32,000 a year earlier and down 29.4% from the prior quarter.

Analysis

PMV Pharmaceuticals (PMVP) Depreciation & Amortization (CF) (2019 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Depreciation & Amortization (CF) at PMV Pharmaceuticals was $123,000, down 74.3% year-over-year; for FY2025, it came in at $133,000, down 88.4% from FY2024.

  • Annual Depreciation & Amortization (CF) shows a five-year compound annual growth rate of -16.0% (FY2020 to FY2025).
  • In prior years, PMV Pharmaceuticals' Depreciation & Amortization (CF) was $1.14 million in FY2024 (-9.0%), $1.26 million in FY2023 (+299.0%), $315,000 in FY2022 (+2.6%) and $307,000 in FY2021 (-3.5%).
  • The Q2 2026 figure stands as the lowest quarterly Depreciation & Amortization (CF) in data going back to Q3 2019.
  • On a year-over-year basis, Depreciation & Amortization (CF) has declined in each of the last seven quarters, with an average decline of 50.8% over the last eight quarters.
  • The strongest year-over-year quarter for Depreciation & Amortization (CF) in the past five years was Q3 2023, with growth of 383.8%; the weakest was Q2 2025, with a decline of 91.4%.
  • According to Business Quant data, Depreciation & Amortization (CF) for the three prior quarters was $34,000 (Q1 2026), $33,000 (Q4 2025) and $32,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 PMV Pharmaceuticals 89.28 Mn -325.89 Mn - 24,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 24,000.00
Mar 31, 2026 34,000.00
Dec 31, 2025 33,000.00
Sep 30, 2025 32,000.00
Jun 30, 2025 32,000.00
Mar 31, 2025 37,000.00
Dec 31, 2024 39,000.00
Sep 30, 2024 371,000.00
Jun 30, 2024 372,000.00
Mar 31, 2024 362,000.00
Dec 31, 2023 359,000.00
Sep 30, 2023 358,000.00
Jun 30, 2023 369,000.00
Mar 31, 2023 171,000.00
Dec 31, 2022 75,000.00
Sep 30, 2022 74,000.00
Jun 30, 2022 82,000.00
Mar 31, 2022 84,000.00
Dec 31, 2021 77,000.00
Sep 30, 2021 80,000.00
API Access

PMV Pharmaceuticals Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=PMVP&period=max&api_key=YOUR_API_KEY